Stock & Company Details
Connect Biopharma Holdings Limited $CNTB
Price:
N/A
N/A
63M
$55M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.76
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
N/A
CNTB technical indicators
Latest Connect Biopharma Holdings Limited (CNTB) indicator readings as of 2026-10-09.
CNTB's 14-day RSI is 29.9, in oversold territory. At $0.87 it is trading 62.4% below its 200-day moving average of $2.31, and below its 50-day average of $1.79. Price sits in the middle of its Bollinger Bands ($0.70 to $1.51). ADX reads 17.0, indicating a range-bound market rather than a trend.
Overview
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
Finance Bot
Ask your questions
Start by typing a question below.
